Trump suggests Pfizer could win U.S. COVID-19 vaccine approval, JNJ to come later

Reuters
FILE PHOTO: The Pfizer logo is seen at their world headquarters in Manhattan, New York, U.S.

WASHINGTON (Reuters) - U.S. President Donald Trump on Monday suggested Pfizer Inc could secure the first U.S. approval of a COVID-19 vaccine in coming weeks, saying a contender by Johnson & Johnson could come later.

Asked which drugmaker could be approved, Trump told Fox News in an interview: "Pfizer's doing really well," adding "Johnson & Johnson ... they'll probably be a little later." He also cited efforts by Moderna Inc and AstraZeneca Plc.

(Reporting by Susan Heavey)